Latest Shareholder Approvals News

Insignia Financial has secured a crucial regulatory approval from APRA, advancing the proposed acquisition by Daintree BidCo. The deal now moves closer to a shareholder vote scheduled for mid-April.

EVE Health Group has announced a $1.3 million capital raising through a placement of shares and free attaching options, aimed at advancing its pharmaceutical product rollout and development pipeline. Several components of the offer await shareholder approval at an upcoming general meeting.

Great Southern Mining has raised $4.6 million through a strongly supported share placement, positioning the company to fast-track drilling at its promising Western Australian gold projects, including the Golden Boulder and Amy Clarke discoveries.

Chariot Resources has raised A$2.1 million through a share placement, attracting institutional and sophisticated investors to back its expanding lithium projects in the US and Nigeria. The placement includes free attaching options, pending shareholder approval.

Sarytogan Graphite Limited has received over $2 million from key investor Dias Sarsenov, advancing its share placement strategy and preparing for a pivotal board appointment. Meanwhile, a significant top-up investment from the EBRD awaits shareholder approval.

Findi Limited has secured $9 million in the first tranche of its $25 million placement, enabling debt reduction and strategic shifts including the cancellation of the Nova transaction and increased ownership in Transaction Solutions International.

TMK Energy has raised $6 million in a heavily oversubscribed placement led by coal seam gas experts, aiming to accelerate drilling and commercialisation at its Gurvantes XXXV project.

Core Lithium has successfully raised A$120 million through a two-tranche institutional placement, securing full funding to restart its Finniss Lithium Operation and target production by Q3 2026.

Lightning Minerals has appointed Troy Brice as CEO, bringing seasoned leadership to spearhead the next phase of exploration at its Mt Turner Gold Project.

Great Dirt Resources has appointed seasoned mining executives Tim Laneyrie and Sam Brooks to its leadership team, aiming to accelerate exploration and strategic acquisitions. These moves coincide with governance changes and a new corporate address, signalling a fresh phase for the ASX-listed explorer.

Chimeric Therapeutics Limited has announced a significant 100-to-1 security consolidation affecting shares, options, and performance rights, pending shareholder approval and set for implementation in April 2026.

ChemX Materials has formalised a $1.2 million unsecured loan with independent investor Ovay Pty Ltd to support its working capital amid ongoing restructuring, with the loan set to convert to shares upon re-listing.